A JAMA THEME ISSUEEdited by Phil B. Fontanarosa, MD
Television watching has been positively associated with obesity and weight gain in children and adults and with type 2 diabetes in men. In this analysis of data from women enrolled in the Nurses' Health Study, a prospective cohort study of female registered nurses aged 30 to 55 years, Hu and colleagues found that sedentary behaviors, especially television watching, were associated with significantly elevated risk of obesity and type 2 diabetes during 6 years of follow-up. Light activities, such as standing or walking around at home, and brisk walking were associated with a significantly lower risk.
See Article
In this 2-year randomized trial, Heshka and colleagues Article compared weight loss and health benefits of a brief counseling and self-help weight loss program with an ongoing commercial program among overweight and obese adults. Weight loss was achieved in both the self-help and commercial groups at 1 year but was significantly greater in the commercial group. During the second year, weight loss was maintained in the commercial group but weight returned to baseline in the self-help group. Tate and colleagues Article compared 1-year outcomes of an Internet weight loss program alone or with behavioral counseling via e-mail among individuals at risk for type 2 diabetes. Decreases in weight, percentage of initial body weight, and waist circumference were significantly greater in the behavioral e-counseling group.
To examine the effect of weight loss on markers of systemic vascular inflammation and insulin resistance, Esposito and colleagues conducted a randomized trial among obese women (BMI ≥30) of lifestyle changes (low-energy Mediterranean-style diet and increased physical activity) designed to achieve a sustained weight reduction of 10% or more. After 2 years, reductions in body mass index, circulating levels of interleukin 6, interleukin 18, and C-reactive protein, and insulin resistance were significantly greater in the lifestyle intervention group than in the control group. Levels of adiponectin, an anti-inflammatory adipocytokine, increased significantly in the intervention group compared with the control group.
Berkowitz and colleagues Article conducted a 6-month randomized trial to compare a comprehensive behavioral weight control program plus sibutramine, an anorexiant medication, with behavior therapy alone for the treatment of obese adolescents. Weight loss and reduction of BMI were significantly greater in the behavior therapy plus sibutramine group. From months 7 through 12, when all participants received open-label sibutramine, adolescents initially treated with sibutramine largely maintained their weight, whereas those who switched from placebo to sibutramine lost additional weight. In a cross-sectional study, Schwimmer and colleagues Article found that severely obese children and adolescents reported significantly lower health-related quality of life than a reference sample of healthy children. The risk of having impaired health-related quality of life was similar among severely obese children and a reference sample of children receiving chemotherapy for cancer. In an editorial, Yanovski and Yanovski Article discuss treatment of pediatric obesity.
Low-carbohydrate diets are currently a popular means to achieve rapid weight loss. Bravata and colleagues Article conducted a systematic review of articles that evaluated low-carbohydrate diets for treatment of obesity. Evidence was insufficient to make recommendations for or against the use of low-carbohydrate diets. Weight loss while using low-carbohydrate diets was principally associated with decreased caloric intake, longer diet duration, and initial body weight but not with reduced carbohydrate intake. In an editorial, Bray Article discusses strategies for obesity treatment.
A practical tool for weight loss counseling adapted from the smoking cessation treatment model.
The growing demand for surgery to treat patients with morbid obesity is prompting a host of ethical and scientific questions about the practice.
Grahic Jump Location
Results of 2 randomized clinical trials provide preliminary evidence of the effectiveness of novel pharmacotherapies for weight loss—zonisamide, an antiepileptic drug, and recombinant human variant ciliary neurotrophic factor, a protein that signals through leptinlike pathways.
For your patients: Information about obesity.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.